⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACAD News
Acadia Pharmaceuticals Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
accessnewswire.com
ACAD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
prnewswire.com
ACAD
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ACADIA Pharmaceuticals Inc. (ACAD) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
ACAD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
accessnewswire.com
ACAD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
globenewswire.com
ACAD
ACADIA Pharmaceuticals Inc. (ACAD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
ACAD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
accessnewswire.com
ACAD
Bronstein, Gewirtz & Grossman, LLC Encourages ACADIA Pharmaceuticals Inc. (ACAD) Shareholders to Inquire about Securities Investigation
accessnewswire.com
ACAD
Prader-Willi Syndrome Market to Expand by 2036 as New Therapeutic Opportunities Address Unmet Clinical Needs | DelveInsight
prnewswire.com
HBIO
SLNO
BMB
ACAD
JAZZ
IONS
OVID
PTC
SRPT
MAR
NVS
LLY
PFE
Bronstein, Gewirtz & Grossman, LLC Is Investigating ACADIA Pharmaceuticals Inc. (ACAD) And Encourages Investors to Connect
accessnewswire.com
ACAD